Alzheimer's Disease and Frontotemporal Dementias

A Review with Particular Reference to Pin1 Protein

 

Home

Pin1 Protein

Our Research

Our TEM Research

Our Publications

Research Team

Alzheimer's Disease

Tauopathies

About this Site

Literature:   A-K ; L-Z ; subject area

Search Site by Subject Area

Disclaimer/ Feedback

Links

Compiled by: Julian Thorpe

 

Neuronal cdc2-like kinase

Please Note: Due to time constraints, the text part of this page has not been updated for some time. However, references are added reasonably frequently.

 
Lew and Wang (1995)reported that neurofilament proteins and the neuron-specific microtubule-associated protein tau are phosphorylated in vivo at sites conforming to the phosphorylation consensus motif of the cell-cycle-control protein kinase, p34cdc2-cyclin. Abnormalities in the phosphorylation of these proteins are associated with neurodegenerative disorders, such as amylotrophic lateral sclerosis and Alzheimer's disease. A cdc2-like kinase composed of cyclin-dependent kinase 5 (cdk5) and a brain-specific regulatory subunit is proposed to be responsible for the cdc2-like phosphorylation of these neuronal proteins.
Liu et al. (1995) found a Cdc2-related kinase in human brains, which was slightly smaller than p34(Cdc2) in molecular mass (approximately 33 kd). It was associated with NFT s and PHF of AD. On the basis of its physical association with NFTs these authors suggested that this 33-kd Cdc2-related kinase might play a role in producing the PHF-Tau characteristic of AD.
With regard to kinase inhibitors, Borgne and Meijer (1999) anticipate the discovery of novel selective and powerful ( kinase ) inhibitors which may be of therapeutic value in AD.
Lee et al. (1999) examined neuronal Cdc2-like kinase activity in prefrontal and cerebellar cortex from  AD and control subjects (corrected either for Cdk5 level or neuronal loss). The ratio of neuronal Cdc2-like kinase activity in prefrontal versus cerebellar cortex was then compared. The ratios were  higher in AD  than the controls, a finding consistent with a role for neuronal Cdc2-like kinase in the pathogenesis of NFT in AD.

Back to Top


Some Related References

Ahlijanian MK; Barrezueta NX; Williams RD; Jakowski A; Kowsz KP; McCarthy S; Coskran T; Carlo A; Seymour PA; Burkhardt JE;Nelson RB; McNeish JD (2000). Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci USA 97: 2910-2915

Bennecib, M, Gong, CX, Grundke-Iqbal, I and Iqbal, K (2000) Role of protein phosphatase-2A and-1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS LETTERS 485: 87-93

Borgne, A and Meijer, L (2000) The search for and potential therapeutic applications of chemical inhibitors of cyclin-dependent kinases. M S-MEDECINE SCIENCES 15: 496-503

Brownlees J, Yates A, Bajaj NP, Davis D, Anderton BH, Leigh PN, Shaw CE, Miller CC (2000) Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci 113: 401-7

BUSH_ML, MIYASHIRO_JS, INGRAM_VM. (1995) ACTIVATION OF A NEUROFILAMENT KINASE, A TAU KINASE, AND A TAU PHOSPHATASE BY DECREASED ATP LEVELS IN NERVE GROWTH FACTOR-DIFFERENTIATED PC-12 CELLS. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, Vol.92, No.6, pp.1861-1865

Back to Top

Ching YP, Qi Z and Wang JH (2000) Cloning of three novel neuronal Cdk5 activator binding proteins. Gene  242: 285-94

Cobb, M.H., Hepler, J.E., Zhen, E., Ebert, D., Cheng, M., Dang, A. and Robbins, D. (1995) Regulation and Structure of the MAP Kinases ERK1 and ERK2. pp. 78-87 In: Alzheimer's Disease: Lessons from Cell Biology. Eds. K.S. Kosik, Y. Christen and D.J. Selkoe. Springer-Verlag.

Crenshaw DG, Yang J, Means AR, Kornbluth S (1998) The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J 17:1315-1327

Dranovsky, A, Vincent, I, Gregori, L, Schwarzman, A, Colflesh, D, Enghild, J, Strittmatter, W, Davies, P and Goldgaber, D (2001) Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology. NEUROBIOLOGY OF AGING 22: 517-528

Giasson_BI, Mushynski_WE. (1997) Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit. JOURNAL OF NEUROSCIENCE, 1997, Vol.17, No.24, pp.9466-9472

Gong C-X, Lidsky T, Weigel J, Zuck L, Grundke-Iqbal, I, Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. J Biol Chem 275: 5535-5544

He, JQ, Lau, AG, Yaffe, MB, Hall, RA (2001) Phosphorylation and cell cycle-dependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 41559-41565

HOSOI_T, UCHIYAMA_M, OKUMURA_E, SAITO_T, ISHIGURO_K, UCHIDA_T, OKUYAMA_A, KISHIMOTO_T, HISANAGA_S.  (1995) EVIDENCE FOR CDK5 AS A MAJOR ACTIVITY PHOSPHORYLATING TAU-PROTEIN IN PORCINE BRAIN EXTRACT. JOURNAL OF BIOCHEMISTRY, 1995, Vol.117, No.4, pp.741-749

Back to Top

Hugon, J., Sindou, P., Lesort, M., Couratier, P., Esclaire, F. and Yardin, C. (1995) Modifications of phosphorylated tau immunoreactivity linked to excitotoxicity in neuronal cultures. pp. 172-179 In: Alzheimer's Disease: Lessons from Cell Biology. Eds. K.S. Kosik, Y. Christen and D.J. Selkoe. Springer-Verlag.

James_ND, Davis_DR, Sindon_J, Hanger_DP, Brion_JP, Miller_CCJ, Rosenberg_MP, Anderton_BH, Propst_F. (1996) Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine threonine kinase Mos. NEUROBIOLOGY OF AGING, 1996, Vol.17, No.2, pp.235-241

Julien JP; Mushynski WE. (1998) Neurofilaments in health and disease.Prog Nucleic Acid Res Mol Biol, 1998, 61:, 1-23

Kosik KS, Ferreira A, Knowles R, Leclerc N and Greenberg SM (1995) Linking amyloid precursor protein processing and tau-related pathology in Alzheimer's disease. pp. 230-240 In: Alzheimer's Disease: Lessons from Cell Biology. Eds. K.S. Kosik, Y. Christen and D.J. Selkoe. Springer-Verlag.

Lee, KY, Clark, AW, Rosales, JL, Chapman, K, Fung, T and Johnston, RN (1999) Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. NEUROSCIENCE RESEARCH 34: 21-29

Lew, J, Huang, QQ, QI, Z, Winkfein, RJ, Aebersold, R, Hunt, T And Wang, JH (1994) A Brain-Specific Activator Of Cyclin-Dependent Kinase-5. NATURE 371: 423-426

LEW_J, QI_Z, HUANG_QQ, PAUDEL_H, MATSUURA_I, MATSUSHITA_M, ZHU_XJ, WANG_JH. (1995) STRUCTURE, FUNCTION, AND REGULATION OF NEURONAL CDC2-LIKE PROTEIN-KINASE. NEUROBIOLOGY OF AGING, 1995, Vol.16, No.3, pp.263-268

LEW_J. and WANG_JH. (1995) NEURONAL CDC2-LIKE KINASE. TRENDS IN BIOCHEMICAL SCIENCES, 1995, Vol.20, No.1, pp.33-37

Back to Top

Lichtenberg-Kraag B, Mandelkow EM, Biernat J, Steiner B, Schroter C, Gustke N, Meyer HE, Mandelkow E. (1992) Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc Natl Acad Sci U S A, 1992 Jun, 89:12, 5384-8

Liu, Wk, Williams, Rt, Hall, Fl, Dickson, Dw And Yen, Sh (1995) Detection Of A Cdc2-Related Kinase Associated With Alzheimer Paired Helical Filaments. AMERICAN JOURNAL OF PATHOLOGY 146: 228-238

Mandelkow, E-M, Biernat, J., Lichtenberg-Kraag, B., Drewes, G., Wille, H., Gustke, N., Baumann, K. and Mandelkow, E. (1995) Phosphorylation of tau and its relationship with Alzheimer paired helical filaments. pp. 103-120 In: Alzheimer's Disease: Lessons from Cell Biology. Eds. K.S. Kosik, Y. Christen and D.J. Selkoe. Springer-Verlag.

Milton, NGN (2001) Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase. NEUROREPORT 12: 3839-3844

Nakamura Y; Hashimoto R; Kashiwagi Y; Aimoto S; Fukusho E; Matsumoto N; Kudo T; Takeda M (2000) Major phosphorylation site (Ser55) of neurofilament L by cyclic AMP-dependent protein kinase in rat primary neuronal culture. J Neurochem 74: 949-59

Pei, JJ, Braak, H, Gong, CX, Grundke-Iqbal, I, Iqbal, K, Winblad, B, Cowburn, RF (2002) Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration . ACTA NEUROPATHOLOGICA 104: 369-376

Perry_G, Roder_H, Nunomura_A, Takeda_A, Friedlich_AL, Zhu_XW, Raina_AK, Holbrook_N, Siedlak_SL, Harris_PLR, Smith_MA. (1999) Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. NEUROREPORT, 1999, Vol.10, No.11, pp.2411-2415

QI_Z, TANG_DM, MATSUURA_I, LEE_KY, ZHU_XJ, HUANG_QQ, WANG_JH. (1995) REGULATORY PROPERTIES OF NEURONAL CDC2-LIKE KINASE. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, Vol.149, pp.35-39

Qi, Z, Zhu, XD, Goedert, M, Fujita, DJ and Wang, JH (1998) Effect of heparin on phosphorylation site specificity of neuronal Cdc2-like kinas. FEBS LETTERS 423: 227-230

Back to Top

Roder, H.M., Eden, P.A. and Ingram, V.M. (1993) Brain protein kinase pk40(erk) converts tau into a PHF-like form as found in Alzheimer's disease. Biochem. Biophys. Res. Comm. 193: 639-647

RODER_HM, HOFFMAN_FJ, SCHRODER_W. (1995) PHOSPHATASE RESISTANCE OF ERK2 BRAIN KINASE PK40(ERK2). JOURNAL OF NEUROCHEMISTRY, 1995, Vol.64, No.5, pp.2203-2212

Sengupta, A, Kabat, J, Novak, M, Wu, QL, Grundke-Iqbal, I and Iqbal, K (1998) Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubule. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 357: 299-309

Sobue, K, Agarwal-Mawal, A, Li, W, Sun, W, Miura, Y and Paudel, HK (2000) Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 16673-16680

Tokuoka H; Saito T; Yorifuji H; Wei F; Kishimoto T; Hisanaga S (2000) Brain-derived neurotrophic factor-induced phosphorylation of neurofilament-H subunit in primary cultures of embryo rat cortical neurons. J Cell Sci 113: 1059-68

Trojanowski, J.Q., Mawal-Dewan, M., Scmidt, M.L., Martin, J. and Lee, VM-Y. (1993) Localisation of the mitogen activated protein kinase ERK2 in Alzheimer's Disease neurofibrillary tangles and senile plaque neurites. Brain Research 618: 333-337

Van den Haute, C, Spittaels, K, Van Dorpe, J, Lasrado, R, Vandezande, K, Laenen, I, Geerts, H and Van Leuven, F (2001) Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice. NEUROBIOLOGY OF DISEASE 8: 32-44

Veeranna, Amin_ND, Ahn_NG, Jaffe_H, Winters_CA, Grant_P, Pant_HC. (1998) Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. JOURNAL OF NEUROSCIENCE, 1998, Vol.18, No.11, pp.4008-4021

VEERANNA, SHETTY_KT, LINK_WT, JAFFE_H, WANG_J, PANT_HC. (1995) NEURONAL CYCLIN-DEPENDENT KINASE-5 PHOSPHORYLATION SITES IN NEUROFILAMENT PROTEIN (NF-H) ARE DEPHOSPHORYLATED BY PROTEIN PHOSPHATASE 2A. JOURNAL OF NEUROCHEMISTRY, 1995, Vol.64, No.6, pp.2681-2690

Veeranna GJ; Shetty KT; Takahashi M; Grant P; Pant HC (2000) Cdk5 and MAPK are associated with complexes of cytoskeletal proteins in rat brain. Brain Res Mol Brain Res, 2000 76: 229-36

Wells NJ, Watanabe N, Tokusumi T, Jiang W, Verdecia MA, Hunter A (1999) The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of  G2/M progression. J Cell Science 112: 3361-3371

Wolowiec, D and Ffrench, M (1996) Cyclin-dependent kinases: Biological functions and involvement in human pathology. M S-MEDECINE SCIENCES 12: 165-173

Zhu, XW, Rottkamp, CA, Raina, AK, Brewer, GJ, Ghanbari, HA, Boux, H and Smith, MA (2000) Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. NEUROBIOLOGY OF AGING 21: 807-803

Back to Top